Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
Roche obesity drug shows 22.5% weight loss in Phase-II trialRoche focuses on catching Lilly in $150 billion obesity…
Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports
BERLIN, March 3 (Reuters) – Swiss pharmaceutical company Roche (ROG.S), opens new tab is aiming for a double-digit…
Roche boosts US presence with new $700 million North Carolina facility
May 12 (Reuters) – Roche Group (ROG.S), opens new tab said on Monday that it plans to invest…
Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
Item 1 of 2 The logo of Swiss drugmaker Novartis is seen at the company’s new cell and…
Roche earnings edge up 5% as forex effects weigh on drug sales growth
Forex effects damp Roche’s drug sales growthCEO Schinecker’s tenure has seen drug trial winsRoche invests in obesity drugs…
US FDA approves Novartis’ gene therapy for rare muscle disorder
Item 1 of 3 The company’s logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz,…